A totally implanted intra-arterial chemotherapy system for advanced maxillary sinus carcinoma

ORL J Otorhinolaryngol Relat Spec. 2010:71 Suppl 1:116-22. doi: 10.1159/000265123. Epub 2010 Feb 24.

Abstract

Conclusion: Both reservoir systems for intra-arterial cisplatin and intravenous sodium thiosulfate infusions are low- invasive, safe and effective procedures for treatment of advanced maxillary sinus carcinoma.

Objectives: To use our reservoir system for intra-arterial high-dose cisplatin infusion therapy in patients with advanced maxillary sinus carcinoma.

Materials and methods: Eight patients with advanced maxillary sinus carcinomas underwent treatment utilizing intra-arterial cisplatin (CDDP) infusion and radiation therapy followed by planned surgical resection. For intra-arterial infusion of high-dose cisplatin, both intra-arterial and intravenous reservoir systems were used.

Results: CDDP was infused 4-6 times (mean 5.1) and the total dose of CDDP was between 690 and 910 mg (mean 771 mg). The response rate was 100 with 50% CR and 50% PR and all patients underwent medial maxillectomy. Only 1 T(4) patient had local recurrence and 1 other patient had bilateral neck metastasis.

MeSH terms

  • Aged
  • Carcinoma / drug therapy*
  • Carcinoma / surgery
  • Cisplatin / administration & dosage*
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Infusion Pumps, Implantable*
  • Infusions, Intra-Arterial
  • Male
  • Maxillary Sinus Neoplasms / drug therapy*
  • Maxillary Sinus Neoplasms / surgery
  • Middle Aged
  • Treatment Outcome

Substances

  • Cisplatin